| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 145, Issue 9 2950-2958, Copyright © 1990 by American Association of Immunologists
ARTICLES |
T Valerius, R Repp, JR Kalden and E Platzer
Department of Internal Medicine III, University of Erlangen-Nurnberg, FRG.
Extracellular killing is regarded as one of the main functions of eosinophils. Therefore, a cytotoxicity assay against antibody-coated Daudi-lymphoma cells was established to measure cytokine effects on peripheral blood eosinophils from healthy volunteers. Optimal time of exposure to cytokines and half optimal concentrations (EC50) were determined and the capability of various cytokines to enhance cytotoxicity of eosinophils was compared. Thus, after 24 h with cytokine, the highest activation of eosinophils was observed with recombinant human rhIFN-gamma (EC50 = 0.2 U/ml), followed by the known activators of eosinophils recombinant human granulocyte/macrophage CSF (rhGM-CSF), rhIL-3, and murine IL-5 (mIL-5). rhIFN-alpha and natural human IFN-beta (nhIFN-beta) enhanced cytotoxicity as well. On the other hand, in short term assays, eosinophils were not stimulated by IFN and the strongest stimulator was rhGM-CSF (EC50 = 0.2 U/ml), followed by rhIL-3, mIL-5, rhTNF, and rhIL-4. With rhTNF-alpha enhancement was more pronounced on freshly isolated eosinophils (EC50 = 0.6 U/ml) and declined with time. No significant stimulation was detected with rhG- CSF, rhIL-1 beta, rhIL-2, rhIL-6, and rhIL-8. On neutrophils, rhIL-8 enhanced cytotoxicity, but the stimulation was weak in relation to other neutrophil activators. Studies on the mechanism of cytotoxic activity revealed that cytotoxicity required opsonization of targets with specific antibody. FMF analysis was performed demonstrating that freshly isolated eosinophils express Fc-gamma RII (CD32), small amounts of Fc-gamma RIII (CD16), but not Fc-gamma RI (CD64). In experiments with blocking antibodies to Fc-gamma R cytotoxicity was restricted to Fc-gamma RII. Expression of Fc-gamma RII was not enhanced by rhGM-CSF, rhTNF-alpha, and mIL-5, but a significant increase in the number of positive cells was observed after incubation with rhIFN-gamma for 24 h (p less than 0.05). In addition, enhanced viability of eosinophils was observed when cultured in the presence of rhIFN-gamma, rhIFN-alpha, rhGM-CSF, and rhTNF-alpha, but not of rhG-CSF and rhIL-2. Thus, IFN appear to be another class of activators of eosinophils, characterized by their delayed type of action.
This article has been cited by other articles:
|
|
 |
|
  J. Yoon, J. U. Ponikau, C. B. Lawrence, and H. Kita Innate Antifungal Immunity of Human Eosinophils Mediated by a {beta}2 Integrin, CD11b J. Immunol., August 15, 2008; 181(4): 2907 - 2915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fujii, H. Tanaka, and S. Abe Interferon-{gamma} Up-regulates Expression of Cysteinyl Leukotriene Type 2 Receptors on Eosinophils in Asthmatic Patients Chest, November 1, 2005; 128(5): 3148 - 3155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Pouladi, C. S. Robbins, F. K. Swirski, M. Cundall, A. N.J. McKenzie, M. Jordana, S. D. Shapiro, and M. R. Stampfli Interleukin-13-Dependent Expression of Matrix Metalloproteinase-12 Is Required for the Development of Airway Eosinophilia in Mice Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 84 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Temkin, B. Kantor, V. Weg, M.-L. Hartman, and F. Levi-Schaffer Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release J. Immunol., September 1, 2002; 169(5): 2662 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Zangrilli Regulation of Eosinophil Viability by Cytokines Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 388 - 390. [Full Text] [PDF]
|
|
|
|
|
|
R. Hoontrakoon, H. W. Chu, S. J. Gardai, S. E. Wenzel, P. McDonald, V. A. Fadok, P. M. Henson, and D. L. Bratton Interleukin-15 Inhibits Spontaneous Apoptosis in Human Eosinophils via Autocrine Production of Granulocyte Macrophage-Colony Stimulating Factor and Nuclear Factor-kappa B Activation Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 404 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Letuve, A. Druilhe, M. Grandsaigne, M. Aubier, and M. Pretolani Involvement of caspases and of mitochondria in Fas ligation-induced eosinophil apoptosis: modulation by interleukin-5 and interferon-{gamma} J. Leukoc. Biol., November 1, 2001; 70(5): 767 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lacy, S. Mahmudi-Azer, B. Bablitz, S. C. Hagen, J. R. Velazquez, S.F. P. Man, and R. Moqbel Rapid Mobilization of Intracellularly Stored RANTES in Response to Interferon-gamma in Human Eosinophils Blood, July 1, 1999; 94(1): 23 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-T. Kim, A. W. Schimming, and H. Kita Ligation of Fc{gamma}RII (CD32) Pivotally Regulates Survival of Human Eosinophils J. Immunol., April 1, 1999; 162(7): 4253 - 4259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Hofstra, I. Van Ark, G. Hofman, F. P. Nijkamp, P. M. Jardieu, and A. J. M. Van Oosterhout Differential Effects of Endogenous and Exogenous Interferon-gamma on Immunoglobulin E, Cellular Infiltration, and Airway Responsiveness in a Murine Model of Allergic Asthma Am. J. Respir. Cell Mol. Biol., November 1, 1998; 19(5): 826 - 835. [Abstract] [Full Text]
|
|
|
|
|
|
X. Zhu, K. J. Hamann, N. M. Munoz, N. Rubio, D. Mayer, A. Hernrreiter, and A. R. Leff Intracellular Expression of Fc{gamma}RIII (CD16) and Its Mobilization by Chemoattractants in Human Eosinophils J. Immunol., September 1, 1998; 161(5): 2574 - 2579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Elovic, H. Ohyama, A. Sauty, J. McBride, T. Tsuji, M. Nagai, P. F. Weller, and D. T. W. Wong IL-4-Dependent Regulation of TGF-{alpha} and TGF-{beta}1 Expression in Human Eosinophils J. Immunol., June 15, 1998; 160(12): 6121 - 6127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Levi-Schaffer, V. Temkin, V. Malamud, S. Feld, and Y. Zilberman Mast Cells Enhance Eosinophil Survival In Vitro: Role of TNF-{alpha} and Granulocyte-Macrophage Colony-Stimulating Factor J. Immunol., June 1, 1998; 160(11): 5554 - 5562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lacy, F. Levi-Schaffer, S. Mahmudi-Azer, B. Bablitz, S. C. Hagen, J. Velazquez, A. B. Kay, and R. Moqbel Intracellular Localization of Interleukin-6 in Eosinophils From Atopic Asthmatics and Effects of Interferon gamma Blood, April 1, 1998; 91(7): 2508 - 2516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Druilhe, M. Arock, L. Le Goff, and M. Pretolani Human Eosinophils Express Bcl-2 Family Proteins: Modulation of Mcl-1 Expression by IFN-gamma Am. J. Respir. Cell Mol. Biol., March 1, 1998; 18(3): 315 - 322. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. J. CALHOUN, B. J. LAVINS, M. C. MINKWITZ, R. EVANS, G. J. GLEICH, and J. COHN Effect of Zafirlukast (Accolate) on Cellular Mediators of Inflammation . Bronchoalveolar Lavage Fluid Findings after Segmental Antigen Challenge Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1381 - 1389. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
